Prevalence of chronic hepatitis B infection in Iran: A review article

Journal of Research in Medical Sciences

Volumn 14, Issue 4, 2009, Pages 249-258

  Poorolajal, Jalal ^a   Majdzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donors; Drug users; Hepatitis B; Iran; Prevalence; Thalassemia

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

AGE DISTRIBUTION; BETA THALASSEMIA; BLOOD DONOR; COMORBIDITY; CROSS-SECTIONAL STUDY; HEMOPHILIA; HEPATITIS B; HUMAN; INFECTION RATE; INTRAVENOUS DRUG ABUSE; IRAN; MASS IMMUNIZATION; POPULATION RISK; PREVENTIVE HEALTH SERVICE; REVIEW; SEX DIFFERENCE;

EID: 70449730766     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. WHO. Hepatitis B immunization. WHO. 2001;WHO/V&B/01.28. Available at URL: http://www.who.int/vaccinesdocuments/
2. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States; recommendations of ACIP part 1: immunization of infants, children, and adolescents. MMWR 2005;54(RR16):1-23.
3. WHO. Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents. WHO. 2001;WHO/V&B/01.31. Available at URL: http://www.who.int/ vaccines-documents/
4. WHO. Hepatitis B. WHO. 2002;WHO/CDS/CSR/LYO/2002.2. Available at URL: http://www.who.int/emc
5. Vaccination and immunity guideline. Ministry of Health and Medical Education Publishing; 1998.
6. Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Medicine 2007;4(10):e297. (Pubitemid 350035454)
7. Alavian SM. Ministry of health in Iran is serious about controlling hepatitis B. Hepatitis Monthly 2007;7(1):3-5.
8. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. Journal of Gastrointestinal and Liver Diseases 2007;16(4):403-406
9. Hekmatdoost A, Shalmani Mohaghegh H, Zali MR. A review of hepatitis B transmission in an organized registry center, Tehran, Iran. Clinical Microbiology & Infection Supplement 2003;9(1 Suppl):84.
10. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000;3(4):192-201.
11. Rezvan H, Abolghassemi H, Amini Kafiabad S. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfusion Medicine 2007;17(6):425-433 (Pubitemid 350198296)
12. AghaJaniPoor K, Zandieh T. Seroepidemiological investigation of hepatitis B,C and HIV virus in safe blood donors of Babol Blood Transfusion Center in 2002. SJIBT 2006;2(7):339-341 (Persian)
13. Alizadeh AH, Ranjbar M, Ansari S, Alavian SM, Shalmani HM, Hekmat L, et al. Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol 2005;11(31):4857-4860 (Pubitemid 41223297)
14. Arab M, Abas Zadeh A, Pour Aboli B, Soleimani Zadeh L, Shahsavari M, Javadi M. Prevalence of HBsAg positivity in blood donors in Bam, 1999-2002. SJIBTO 2006;3(3):277-280 (Persian)
15. Attarchi Z, Ghafouri M, Hajibaygi B, Assari SH, Alavian SM. Donor deferral and blood-borne infections in blood donors of Tehran. SJIBTO 2006;2(7):353-364 (Persian)
16. Bozorgi SH, Ahmadzad Asl M, Ramazani H, Kargarfard H, Alavian SM. Study of viral infections prevalence in blood donors of Qazvin province in different time intervals and during Bam earthquake. Govaresh 2007;11(4):242-248 (Persian)
17. Emamghorashi F, Fathi GH, Mohtashami A. Evaluation of demographic characteristics and hepatitis B,C and HIV prevalence among blood donors in Jahrom, 2001-2003. SJIBTO 2006;2(7):373-378 (Persian)
18. Farhat A, Khademi Gh, Mazlouman ShJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Medical Journal 2003;24(5):549-551 (Pubitemid 36826819)
19. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2000;6(5-6):1114-1116
20. Habibzadeh S, Davarnia B, Bazazataei A, Bagherzadeh S, Kholgh GRH. Epidemiological evaluation of transfusion transmitted diseases in Ardabil in Tasoua and Ashoura 1381(2003). SJIBTO 2004;1(2):55-60. (Persian)
21. Hariri MM, Akbari N, Yavari F, Javadi E, Javer SH. Prevalence of hepatitis B, C and HIV markers in thalassemic and haemophilic patients in Isfahan, Iran, 2004. SJIBTO 2006;2(3):201-204 (Persian)
22. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behavior". Sexually Transmitted Infections 2005;81(2):185.
23. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003;21(17-18):1948-1951 (Pubitemid 36428785)
24. Jalali Far M, Torabi Zadeh Maatoghi J, Sajadi SM, Paridar M, Ghasem Zadeh A, Nasimian A. Significant reduce in hepatitis B prevalence among blood donors admitted to an Ahwaz blood transfusion service due to educational and vaccination programmes. 17th Europian Congress of Clinical Microbiology and Infectious Diseases; 2007 Mar 31-Apr04; Munich, Germany. Hoboken: Wiley 2007.
25. Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iranian Journal of Public Health 2006;35(4):33-36 (Pubitemid 46178736)
26. Karimi M, Ghavanin AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. Journal of Pediatric and Child Health 2001;37(6):564-566 (Pubitemid 34042952)
27. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Archive of Iranian Medicine 2003;6(1):1-4. (Pubitemid 36748005)
28. Mahdaviani FS, Saremi S, Maghsoudlu M, Pour Fathollah AA. Prevalence of blood transmitted viral infections in regular and non-regular donors of Arak blood center. SJIBTO 2006;2(7):343-351 (Persian)
29. Mansour-Ghanaei F, Fallah MS, Jafarshad R, Joukar F, Salari A, Tavafzadeh R. Prevalence of hepatitis B surface antigen and hepatitis C virus antibody and their risk factors among Guilan's volunteer blood donors (1998-2003). Hepatitis Monthly 2007;7(4):239-241
30. Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan. Med Sci Monit 2002;8(12):CR797-800.
31. Masaeli Z, Jaberi MR, Magsudlu M. A comparison of seroprevalence of blood-borne infections among regular, sporadic, and first-time blood donors in Isfahan. SJIBTO 2006;2(7 Suppl):301-307 (Persian)
32. Mirmomen SH, Alavian SM, Hajari Zadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Archives of Iranian Medicine 2006;9(4):319-323 (Pubitemid 44803571)
33. Moniri R, Mosayebii Z, Mossavi G. Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors. Iranian J Publ Health 2004;33(4):38-42.
34. Pourazar A, Akbari N, Hariri M, Yavari F, Akbari Sh. Evaluation of demographic profiles and prevalence of major viral markers in first time vs repeat blood donors in Esfahan. SJIBTO 2006;2(7 Suppl):323-329 (Persian)
35. Roshandel Gh, Semnani Sh, Keshtkar A, Joshaghani HR, Moradi A, Kalavi Kh, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian Journal of Medical Sciences 2007;61(5):263-268
36. Sanei-Moghaddam E, Savadkoohi S, Rakhshani F. Prevalence of hepatitis B and C in patients with major thalassaemia referred to Ali-Asghar hospital in Zahedan in 2002. SJIBTO 2004;1(1):19-26.
37. Tavakkoli H, Mir-Nasseri MM, Poustchi H, Afshar P, Motalebi MN, Mohammadkhani A, et al. Prevalence and risk factors of hepatitis B infection in injection drug users, Tehran (2001-2002). Hepatitis Monthly 2008;8(1):29-33.
38. Torabi SA, Abed-Ashtiani K, Dehkada R, Moghadam AN, Bahram MKh, Dolatkhah R, et al. Prevalence of hepatitis B, C and HIV in hemophiliac patients of East Azarbaijan in 2004. SJIBTO 2006;2(7 Suppl):291-299 (Persian)
39. Torabi SE, Abed Ashtiani K, Dehkhoda R, Moghadam AN, Sorkhabi RA, Bahram MK, et al. Prevalence of hepatitis B and C in thalassemic patients of East Azarbaijan in 2003. SJIBTO 2005;2(4):115-122 (Persian)
40. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, IR.Iran. Hepatitis Monthly 2005;5(4):117-122
41. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in Islamic Republic of Iran. East Mediterranean Health Journal 2005;11(1-2):62-67 (Pubitemid 43308567)
42. Amini S, Mahmoodi M, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993;96(5):277-287 (Pubitemid 23317270)
43. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high-risk groups in Iran. Vox Sang 1979;37(3):182-186 (Pubitemid 10250678)
44. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 1996;2(2):290-298 (Pubitemid 126414330)
45. Whitehead A. Meta-analysis of controlled clinical trials. 1st ed. New Jersey: John Wiley & Sons Ltd; 2002.